Search
CY 1899
go.drugbank.com/drugs/DB17797ExperimentalSynonyms: L-Valine, N2,N6-bis(1-oxohexadecyl)-L-lysyl-L-seryl-L-seryl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-?, -glutamyl-L-alanyl-L-alanyl-L-alanyl-L-phenylalanyl-Hexylresorcinol
go.drugbank.com/drugs/DB11254ApprovedHexylresorcinol is a substituted dihydroxybenzene. It exhibits antiseptic, anthelmintic, and local anesthetic properties. … It can be found in topical applications for minor skin infections and in oral solutions or throat lozenges for pain relief and first aid antiseptic.
Synonyms: 4-hexylresorcinol, 4-hexyl-1,3-benzenediolProducts: -s.miel Et Eucalypt., Myxcin-CBezafibrate
go.drugbank.com/drugs/DB01393ApprovedInvestigationalIt decreases low density lipoproteins and increases high density lipoproteins.
Synonyms: 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acidCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 InhibitorsDabigatran etexilate
go.drugbank.com/drugs/DB06695ApprovedInvestigational[A177463] In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary.[A177463] Dabigatran etexilate was approved by the FDA in 2010.[L6022] … [A177463, A6970, L34675, L34680] Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients in whom anticoagulation therapy is indicated.
Categories: Heterocyclic Compounds, 1-Ring, P-glycoprotein substratesProducts: Dabigatranetexilat 1A Pharma 75 mg - Hartkapseln, Dabigatranetexilat 1A Pharma 110 mg - HartkapselnRoxadustat
go.drugbank.com/drugs/DB04847ApprovedInvestigationalIt works by reducing the breakdown of the hypoxia-inducible factor (HIF), which is a transcription factor that stimulates red blood cell production in response to low oxygen levels. … Roxadustat is a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor used to treat anemia associated with chronic kidney disease.
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-RingProducts: Ernevod 50 mg Film Kaplı Tablet (12 adet), EVRENZO 50 MG FİLM KAPLI TABLET, 12 ADETPazopanib
go.drugbank.com/drugs/DB06589ApprovedInvestigationalPazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Categories: MATE 1 Inhibitors, Heterocyclic Compounds, 1-RingProducts: VOTRIENT® 200 MG, VOTRIENT® 400 MGUbidecarenone
go.drugbank.com/drugs/DB09270ApprovedInvestigationalNutraceutical[A7874] It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation. … It is fundamental for cells that have a high metabolic demand.
Mixtures: Coen.q10w.vit.c and E Beta-car.se Cu Zn Mn, Q 10 Suprabio +L-CarnitineCategories: P-glycoprotein substratesStage 3 Type 1 Diabetes Mellitus
go.drugbank.com/conditions/DBCOND0153000Drugs: TeplizumabSynonyms: Stage 3 Type 1 Diabetes MellitusMaraviroc
go.drugbank.com/drugs/DB04835ApprovedInvestigationalMaraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is a chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the … It was originally labelled as UK-427857 during development but was assigned the Maraviroc name as it entered trials. It was approved for use by the FDA in August, 2007.
Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 SubstratesProducts: CELSENTRI® 150 MG, CELSENTRI® 300 MGStearic acid
go.drugbank.com/drugs/DB03193ApprovedIt is a waxy solid.
Synonyms: n-octadecanoic acid, C18:0Mixtures: Huile D'onagre Vitamin E, Jayjun Real Water Shining Cleansing Foa M